首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2084776

腸病毒檢測套組市場：依檢測方法、最終用戶、分類及地區分類

Enteroviruses Testing Kit Market, By Testing, By End User, By Classification, By Geography

出版日期: 2026年06月04日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，腸病毒檢測套組市場規模將達16.9億美元，2033年將達32億美元。預計從2026年到2033年，該市場將以9.5%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	16.9億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.50%	2033年市場規模預測：	32億美元

由於腸病毒感染疾病的日益普遍、手足口病發病率的上升、感染疾病監測計畫的擴展以及分子診斷技術的日益普及，市場正經歷著顯著成長。腸病毒可引起多種疾病，包括手足口病、病毒性腦膜炎、腦炎、急性弛緩性麻痺和呼吸道感染疾病，因此對快速、準確的診斷解決方案的需求龐大。

腸病毒檢測套組在疾病早期發現、集體爆發控制、流行病學監測和臨床決策中發揮至關重要的作用。該市場主要由快速檢測套組和基於逆轉錄聚合酵素鏈鎖反應（RT-PCR）的診斷試劑盒組成。其中，RT-PCR檢測因其卓越的靈敏度、特異性和快速出結果的能力，已成為領先的診斷方法，並成為醫院、公共衛生實驗室和研究機構的首選。

分子診斷、多重PCR技術、檢查室自動化和基因組監測的進步正在顯著改變腸病毒檢測模式。新興經濟體政府加大對疾病監測計畫的投入，並持續擴大醫療基礎設施，進一步推動了市場成長。此外，人們對感染疾病防範和集體爆發控制意識的提高，也促進了全球先進腸病毒診斷檢測方法的應用。

市場動態

受感染疾病集體爆發以及對精準診斷工具需求的推動，腸病毒檢測套組市場正經歷強勁成長。成長要素之一是全球腸病毒感染疾病負擔的不斷加重。公共衛生部門估計，光是美國每年就有約1,000萬至1,500萬例非脊髓灰質炎感染疾病病例，凸顯了疾病負擔的嚴重性以及對有效診斷檢測方案的迫切需求。

推動市場擴張的另一個主要因素是手足口病（HFMD）疫情的日益嚴重，尤其是在亞太地區國家。克沙奇病毒和腸病毒A71仍然是手足口病的主要病原體，這持續推動檢查室對診斷檢測和監測活動的需求。各國政府和醫療機構正日益加強篩檢和疫情監測計劃，以強化疾病防治工作。

分子診斷技術的快速發展也加速了市場成長。 RT-PCR和多重PCR平台具有診斷準確率高、檢測速度快、能夠同時從單一患者檢體中檢測多種腸病毒株等優點。這些技術進步提高了檢查室效率，並增強了其應對集體爆發的能力。

由於醫院擁有先進的檢測基礎設施、龐大的患者群體以及分子診斷平台的日益普及，它們仍然是最大的終端用戶群。公共衛生實驗室和研究機構也正在增加腸病毒檢測套組的採購，以支持國家疾病監測計畫和流行病學研究舉措。

然而，市場成長面臨許多挑戰。先進的RT-PCR系統和分子檢測套組高成本，可能限制其在資源匱乏的醫療機構中的應用。此外，發展中地區檢測基礎設施和熟練診斷專家的短缺也可能阻礙市場滲透。儘管存在這些挑戰，但在預測期內，隨著醫療基礎設施、檢查室現代化和感染疾病控制項目投資的增加，預計市場將迎來顯著成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數分析了腸病毒檢測套組市場的主要參與者：公司概況、服務組合、主要發展、財務績效和策略。
本報告提供的見解將使行銷負責人和經營團隊能夠就未來的服務創新、市場擴張和策略合作夥伴關係做出明智的決策。
《腸病毒檢測套組市場》報告的目標受群眾外包括投資者、服務供應商、製藥公司、監管機構和金融分析師等各類相關人員。
相關人員可以從用於評估腸病毒檢測套組市場的系統分析框架和策略矩陣中受益。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Sartorius AG
- Abbexa Ltd
- Cepheid Inc.
- Aviva Systems Biology Corporation
- Cusabio Technology LLC
- ELITech Group SAS
- Creative Diagnostics
- Quidel Corporation
- DiaSorin
- bioMerieux
- Primerdesign Ltd
- QIAGEN NV
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4256

Enteroviruses Testing Kit Market is estimated to be valued at USD 1.69 Bn in 2026 and is expected to reach USD 3.20 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1.69 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.50%	2033 Value Projection:	USD 3.20 Bn

The market is witnessing substantial growth owing to the increasing prevalence of enterovirus infections, rising incidence of hand, foot, and mouth disease (HFMD), expanding infectious disease surveillance programs, and growing adoption of molecular diagnostic technologies. Enteroviruses are responsible for a wide range of illnesses including HFMD, viral meningitis, encephalitis, acute flaccid paralysis, and respiratory infections, creating significant demand for rapid and accurate diagnostic solutions.

Enteroviruses testing kits play a critical role in early disease detection, outbreak management, epidemiological surveillance, and clinical decision-making. The market primarily comprises rapid detection tests and RT-Polymerase Chain Reaction (RT-PCR)-based diagnostic kits. Among these, RT-PCR testing has emerged as the dominant diagnostic method due to its superior sensitivity, specificity, and ability to provide rapid results, making it the preferred choice for hospitals, public health laboratories, and research institutions.

Advancements in molecular diagnostics, multiplex PCR technologies, laboratory automation, and genomic surveillance are significantly transforming the enteroviruses testing landscape. Increased government investments in disease monitoring programs and the expansion of healthcare infrastructure across emerging economies are further supporting market growth. Additionally, growing awareness regarding infectious disease preparedness and outbreak control is encouraging wider adoption of advanced enterovirus diagnostic testing worldwide.

Market Dynamics

The Enteroviruses Testing Kit Market is experiencing robust growth due to increasing concerns regarding infectious disease outbreaks and the need for accurate diagnostic tools. One of the primary growth drivers is the rising burden of enterovirus infections globally. According to public health estimates, approximately 10-15 million non-polio enterovirus infections occur annually in the United States alone, highlighting the substantial disease burden and the necessity for effective diagnostic testing solutions.

Another major factor supporting market expansion is the growing prevalence of HFMD outbreaks, particularly across Asia-Pacific countries. Coxsackievirus and Enterovirus A71 remain the leading causes of HFMD, driving continuous demand for laboratory-based diagnostic testing and surveillance activities. Governments and healthcare organizations are increasingly implementing screening and outbreak monitoring programs to strengthen disease control efforts.

The rapid advancement of molecular diagnostic technologies is also accelerating market growth. RT-PCR and multiplex PCR platforms offer high diagnostic accuracy, reduced turnaround time, and the ability to simultaneously detect multiple enterovirus strains from a single patient sample. These technological improvements are enhancing laboratory efficiency and improving outbreak response capabilities.

Hospitals continue to represent the largest end-user segment due to their advanced laboratory infrastructure, high patient volumes, and increasing adoption of molecular diagnostic platforms. Public health laboratories and research institutions are also increasing procurement of enterovirus testing kits to support national disease surveillance programs and epidemiological research initiatives.

However, certain challenges may hinder market growth. High costs associated with advanced RT-PCR systems and molecular testing kits can limit adoption in resource-constrained healthcare settings. Furthermore, limited laboratory infrastructure and shortages of skilled diagnostic professionals in developing regions may restrict market penetration. Despite these challenges, increasing investments in healthcare infrastructure, laboratory modernization, and infectious disease preparedness programs are expected to create significant growth opportunities throughout the forecast period.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Enteroviruses Testing Kit Market based on the following parameters - company highlights, service portfolio, key developments, financial performance, and strategies
Key companies covered as a part of this study include Sartorius AG, Abbexa Ltd, Cepheid Inc., Aviva Systems Biology Corporation, Cusabio Technology LLC, ELITech Group SAS, Creative Diagnostics, Quidel Corporation, DiaSorin, bioMerieux, Primerdesign Ltd, and QIAGEN
Insights from this report would allow marketers and management authorities to make informed decisions regarding future service innovations, market expansion, and strategic partnerships
The Enteroviruses Testing Kit Market report caters to various stakeholders including investors, service providers, pharmaceutical companies, regulatory bodies, and financial analysts
Stakeholders would benefit from structured analytical frameworks and strategy matrices used in evaluating the Enteroviruses Testing Kit Market

Market Segmentation

By Testing (Revenue, USD Bn, 2026-2033)
Rapid Detection Test
RT- Polymerase Chain Reaction (PCR)
By End User (Revenue, USD Bn, 2026-2033)
Hospitals
Speciality Clinics
Research Laboratories
By Classification (Revenue, USD Bn, 2026-2033)
Coxsackievirus
Coxsackie A Virus
Duck Hepatitis Virus III
Enterovirus A71
Duck Hepatitis Virus 1a
By Region (Revenue, USD Bn, 2026-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Companies
Sartorius AG
Abbexa Ltd
Cepheid Inc.
Aviva Systems Biology Corporation
Cusabio Technology LLC
ELITech Group SAS
Creative Diagnostics
Quidel Corporation
DiaSorin
bioMerieux
Primerdesign Ltd
QIAGEN N.V.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Testing
- Market Snapshot, By End User
- Market Snapshot, By Classification
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Enteroviruses Testing Kit Market, By Testing, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Rapid Detection Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
RT- Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Enteroviruses Testing Kit Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Speciality Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Enteroviruses Testing Kit Market, By Classification, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Coxsackievirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Coxsackie A Virus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Duck Hepatitis Virus III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Enterovirus A71
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Duck Hepatitis Virus 1a
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Enteroviruses Testing Kit Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Classification, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Classification, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Classification, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Classification, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Classification, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Classification, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Sartorius AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Abbexa Ltd
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cepheid Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Aviva Systems Biology Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Cusabio Technology LLC
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- ELITech Group SAS
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Creative Diagnostics
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Quidel Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- DiaSorin
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- bioMerieux
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Primerdesign Ltd
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- QIAGEN N.V.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views